Tenaya Therapeutics
TNYA
Tenaya Therapeutics (TNYA) news
Recent news
Tenaya Therapeutics Q2 net income USD -43.393 million
AInvest Wire · Aug 5, 2026Tenaya Therapeutics Q2 operating expenses USD 45.198 million
AInvest Wire · Aug 5, 2026Tenaya Therapeutics Q2 pretax profit USD -43.393 million
AInvest Wire · Aug 5, 2026Tenaya Therapeutics reports inducement grants under Nasdaq listing rule 5635(c)(4)
AInvest Wire · Jul 15, 2026Tenaya Therapeutics appoints Eric Hylleberg as chief financial officer
AInvest Wire · Jun 29, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.